The Navigation Model of Therapy: Why Awareness Changes Everything
November 16, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Dysport
(United States) [Available]Synonyms :
Class :
Anticholinergics and ganglionic blocking agents
Brand Name :
Dysport
(United States) [Available]Synonyms :
Class :
Anticholinergics and ganglionic blocking agents
Dosage Forms & Strengths
Injection- powder for reconstitution
300 units/vial
500 units/vial
Dosage Forms & Strengths
Injection-powder for reconstitution
300 units/vial
500 units/vial
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
neuromuscular-Blocking Agents may enhance the adverse neuromuscular effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may enhance the risk of adverse effect of corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may have an increased adverse neuromuscular effect when combined with corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the adverse neuromuscular effect of corticosteroids
may increase the neuromuscular adverse effect of corticosteroids
may increase the neuromuscular effect of corticosteroids
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of Inhalational Anesthetics
neomycin/polymyxin B/gramicidin ophthalmic
may increase the neuromuscular-blocking effect of Polymyxin B
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
The interaction may enhance the risk of anaphylaxis
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
aluminum hydroxide/magnesium hydroxide
may increase the neuromuscular-blocking effect of magnesium Salts
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic drugs
anticholinergic agents increase the effect of cimetropium
it increases the effect of constipation of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of ulcer formation of anticholinergic agents
it increases the effect of anticholinergic agents
it increases the effect of anticholinergic agents
anticholinergic agents increase the effect of tiotropium
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
It may increase the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the neuromuscular-blocking effect of neuromuscular-blocking agents
may enhance the arrhythmogenic effect of cardiac glycosides
may enhance the arrhythmogenic effect of cardiac glycosides
may enhance the arrhythmogenic effect of cardiac glycosides
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may increase the serum concentration of thiazide and thiazide-Like diuretics
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may enhance the risk of adverse effect of Opioid agonists
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the effect of gastrointestinal drugs
may reduce the therapeutic effect
may increase the tachycardic effect
may increase the tachycardic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may enhance the adverse/toxic effect
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects
may increase the risk of adverse effects of opioid agonists
may increase the risk of adverse effects of opioid agonists
may increase the risk of adverse effects of opioid agonists
may increase the risk of adverse effects of opioid agonists
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may enhance the risk of adverse effect
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
it may reduce the neuromuscular blocking effect of Neuromuscular Blocking Agents
loop Diuretics may reduce the neuromuscular blocking effect of neuromuscular-Blocking Agents.
loop Diuretics may reduce the neuromuscular blocking effect of neuromuscular-Blocking Agents.
loop Diuretics may reduce the neuromuscular blocking effect of neuromuscular-Blocking Agents.
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
amoxicillin and clavulanate potassium
Enhance the neuromuscular effect of NMBAs
lansoprazole, amoxicillin, and clarithromycin
Enhance the neuromuscular effect of NMBAs
bismuth subcitrate, metronidazole and tetracycline
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
Enhance the neuromuscular effect of NMBAs
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
may increase the arrhythmogenic effect of cardiac glycosides
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
magnesium salts may increase the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may reduce the effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the therapeutic effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
may enhance the effect of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the toxicity of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
bismuth subcitrate, metronidazole and tetracycline
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
they increase the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
may increase the therapeutic effect of antibiotics
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agents
may diminish the neuromuscular-blocking effect of neuromuscular blocking agents
methyldopa/hydrochlorothiazide
may increase the neuromuscular blocking effect of thiazide and thiazide like diuretics
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the cholinergic effect of cholinergic agents
may increase the neuromuscular-blocking effect of magnesium Salts
may increase the neuromuscular blocking effect of magnesium salts
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the neuromuscular-blocking effect of Local Anesthetics
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the risk of adverse effect of other cholinergic antagonists
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may increase the therapeutic effect of neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may diminish the serum concentration when combined with neuromuscular-blocking agents
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased arrhythmogenic effect when combined with cardiac glycosides
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may decrease the neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increasingly adverse effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
bismuth subcitrate, metronidazole and tetracycline
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may reduce the therapeutic effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
may enhance the neuromuscular-blocking effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
reduce the therapeutic effect
may reduce the therapeutic effect of secretin
may decrease the neuromuscular-blocking effect when combined
local anesthetics increase the efficacy of neuromuscular blockers
may increases the neuromuscular-blocking effect of Magnesium Salts
may increase the neuromuscular-blocking effect of Magnesium Salts
may have an increased therapeutic effect when combined with neuromuscular blocking drugs
neomycin/polymyxin B/bacitracin topical
may have an increased therapeutic effect when combined with neuromuscular blocking drugs
anticholinergic agents increase the toxic or adverse effects of topiramate
it increases the effect of anticholinergic agents
they decrease the efficacy of anticholinergic agents
they decrease the efficacy of anticholinergic agents
anticholinergic agents increase the effect of cannabinoid products
anticholinergic agents increase the effect of cannabinoid products
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
anticholinergic agents decrease the efficacy of gastrointestinal agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
lansoprazole, amoxicillin, and clarithromycin
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
may have an increased neuromuscular-blocking effect when combined with neuromuscular-blocking agents
benzoyl peroxide, clindamycin phosphate, adapalene
caution is recommended when using this medication in patients using other neuromuscular blocking agents, as the clindamycin in this medication enhances the neuromuscular blocking properties of other neuromuscular agents
may increase the respiratory depressant effect
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
May diminish the effects of pharmacodynamic antagonism
may have an increasingly adverse effect when combined with products containing botulinum toxin
may have an increasingly adverse effect when combined with products containing botulinum toxin
may have an increasingly adverse effect when combined with products containing botulinum toxin
may have an increasingly adverse effect when combined with products containing botulinum toxin
may have an increasingly adverse effect when combined with products containing botulinum toxin
it increases the effect of neuromuscular blockage of neuromuscular-blocking agents
anticholinergic agents increase the constipating effect of clozapine
Adverse drug reactions:
Frequency Defined
>10%
Dysphagia
Injection site discomfort
Muscle weakness
Fatigue
Dry mouth
Headache
1-10%
Facial paresis
Dyspnea
Dysphonia
Pregnancy warnings:
Breastfeeding warnings:
Pregnancy Categories:
Patient Information Leaflet
Generic Name: abobotulinumtoxinA
Why do we use abobotulinumtoxinA ?
abobotulinumtoxinA belongs to the class of anticholinergic agents used to treat cervical dystonia, muscle spasms, and stiffness (spasticity)
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
